Literature DB >> 35032172

When the harms of intensive care treatment outweigh the benefits, the default use of time-limited trials is not ethically justifiable.

Thomas M Donaldson1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35032172     DOI： 10.1007/s00134-021-06607-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Triage of intensive care patients: identifying agreement and controversy.

Authors:  Charles L Sprung; Marion Danis; Gaetano Iapichino; Antonio Artigas; Jozef Kesecioglu; Rui Moreno; Anne Lippert; J Randall Curtis; Paula Meale; Simon L Cohen; Mitchell M Levy; Robert D Truog
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

Review 2.  Causes and consequences of disproportionate care in intensive care medicine.

Authors:  Erwin J O Kompanje; Ruth D Piers; Dominique D Benoit
Journal:  Curr Opin Crit Care       Date:  2013-12       Impact factor: 3.687

3.  Harming patients by provision of intensive care treatment: is it right to provide time-limited trials of intensive care to patients with a low chance of survival?

Authors:  Thomas M Donaldson
Journal:  Med Health Care Philos       Date:  2021-01-15

4.  Raising awareness for time-limited trial discussion upon ICU triage and admission.

Authors:  Emmanuel Hei-Lok Cheung; Jonathan Chun-Hei Cheung; Yu-Yeung Yip
Journal:  Intensive Care Med       Date:  2021-12-01       Impact factor: 41.787
  4 in total
  2 in total

1.  Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional.

Authors:  Thomas M Donaldson
Journal:  Intensive Care Med       Date:  2022-03-01       Impact factor: 41.787

2.  The Impact of Signing Do-Not-Resuscitate Orders on the Use of Non-Beneficial Life-Sustaining Treatments for Intensive Care Unit Patients: A Retrospective Study.

Authors:  Shang-Sin Shiu; Ting-Ting Lee; Ming-Chen Yeh; Yu-Chi Chen; Shu-He Huang
Journal:  Int J Environ Res Public Health       Date:  2022-08-03       Impact factor: 4.614
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.